- ►endojournals.org X Zhang, GA Horwitz, TR Prezant, A … - Molecular Endocrinology, 1999 - Endocrine Soc Despite advances in characterizing the pathophysiology and genetics of pituitary
tumors, molecular mechanisms of their pathogenesis are poorly understood.
Recently, we isolated a transforming gene [pituitary tumor-transforming ... Cited by 280 - Related articles - BL Direct - All 9 versions
- ►endojournals.org X Zhang, GA Horwitz, AP Heaney, M … - Journal of Clinical Endocrinology & Metabolism, 1999 - Endocrine Soc We recently cloned a novel pituitary tumor transforming gene (PTTG). Here we
report PTTG expression in human pituitary adenomas and in normal pituitary
tissue. In situ hybridization revealed PTTG expression in nonfunctioning ... Cited by 270 - Related articles - BL Direct - All 6 versions
- ►endocrinology-journals.org [PDF] BM Arafah, MP Nasrallah - Endocrine-Related Cancer, 2001 - Soc Endocrinology Pituitary tumors are frequently encountered intracranial neoplasms. They present
with a variety of clinical manifestations that include symptoms and signs of
excessive hormone secretion by the tumor, signs of hormone deficits by the ... Cited by 85 - Related articles - BL Direct - All 6 versions
- ►annals.org MJ Kupersmith, C Rosenberg, D Kleinberg - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To investigate the potential risk for developing visual loss ... Cited by 69 - Related articles - BL Direct - All 5 versions
RA Smith, S Melmed, B Sherman, J Frane, TL … - Muscle & nerve, 1993 - interscience.wiley.com Based on the known trophic effects of growth hormone (GH) on nerve and muscle 75
patients with ALS were treated for up to 18 months with synthetic human growth
hormone (Protropin) or a placebo. The course of ALS was assessed serially ... Cited by 44 - Related articles - BL Direct - All 4 versions
S Yamada, T Aiba, K Takada, Y Ozawa, T … - Clinical Endocrinology, 1996 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 38 - Related articles - BL Direct - All 4 versions
G Benker, C Jaspers, G Häusler, D Reinwein - Journal of Molecular Medicine, 1990 - Springer Summary. 1. Prolactin is a 21,500 Dalton single- chain polypeptide hormone but
may occur in 50 kDa and 150 kDa molecular variants. 2. These large PRL variants
may be secreted pre- dominantly; this condition is termed "macropro- ... Cited by 35 - Related articles - All 4 versions
G Ramirez, J Navarte, PA Bittle, C Ayers- … - Nephron, 1991 - content.karger.com We evaluated the response of 20 male patients, 13 cadaveric kidney and 7 heart
transplant recipients, to the administration of 100 µg GnRH
(gonadotropin-releasing hormone) and 500 µg TRH (thyrotropic-releasing ... Cited by 31 - Related articles - All 6 versions
K Thapar, K Kovacs, PJ Muller - Baillière's clinical endocrinology and metabolism, 1995 - Elsevier V Alvaro, L Levy and C Deburay et al., Invasive human pituitary tumors express a
point mutated alpha-protein kinase-C, Journal of Clinical Endocrinology and
Metabolism 77 (1993), pp. 1125–1139. ... SL Asa, N Ryan and K Kovacs et ... Cited by 30 - Related articles - BL Direct - All 3 versions
- ►anesthesiaandanalgesia.com EC Nemergut, AS Dumont, UT Barry, ER … - Anesthesia & Analgesia, 2005 - anesthesiaandanalgesia.com Pituitary adenomas often present with the symptoms of hormonal hypersecretion,
and although medical therapy is available for most hyperfunctioning states, it
is not curative. As a result, transsphenoidal pituitary surgery has become ... Cited by 26 - Related articles - BL Direct - All 18 versions
